Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics
Clinical trial NCT05448651 · COMPLETED
Trial details
- NCT number
- NCT05448651
- Sponsor
- Upstream Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-08
- Primary completion
- 2023-08-15
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.